VivoSeq
Cardiovascular

Stroke, Acute

3

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

Stroke, Acute is an early-stage landscape with 3 programs across 2 companies. The most active players are Acticor Biotech, Eli Lilly. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Acticor Biotech

1 program

PreclinicalEli Lilly logo

Eli Lilly

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical1

Glenzocimab

Acticor Biotech

Phase 1
No programs
Phase 2
No programs
Phase 32

Tirofiban

Medicure

Dual Antiplatelet Therapy

Seoul St. Mary's Hospital

Approved
No programs

Analysis

Modality Breakdown

67%

Small molecule

2 of 3 classified programs — the dominant modality here.

33%ALL OTHERSMonoclonal antibody133%

Small molecule leads; the ring shows all 3 classified programs, each share of the total. Modality classified for 75% of 4 pipeline programs.

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Recruiting2 · 50%

Clinical Trials

Trial Activity

Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study
Completed·AAssistance Publique - Hôpitaux de Paris·Preclinical·NCT05559398·108 enrolled
Stroke Alarm Efficacy Trial
Recruiting·—·Preclinical·NCT06315192·500 enrolled
Biological Dating of Cerebral Ischemia With Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
Completed·CCentral Hospital, Nancy, France·Preclinical·NCT03364296·935 enrolled
Efficacy and Safety of Tirofiban Therapy in Acute Ischemic Stroke Patients Beyond the Time Window Guided by High-Resolution Magnetic Resonance Imaging
Recruiting·Weifang Medical University·Phase 3·NCT07379190·458 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)